SEARCH

SEARCH BY CITATION

References

  • 1
    Darsow U, Luebbe J, Taieb JA, Seidenari S, Wollenberg A, Calca AM et al. Position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2005;19:286295.
  • 2
    Proksch E, Foelster-Holst R, Jensen JM. Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci 2006;43:159169.
  • 3
    Mihm MC, Soter NA, Dvorak HF. The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 1976;67:305312.
  • 4
    Wollenberg A, Wen S, Bieber T. Phenotyping of epidermal dendritic cells: clinical applications of a flow cytometric micromethod. Cytometry 1999;37:147155.
  • 5
    Berth-Jones J, Damstra RJ, Golsch S, Livden JK, Van Hooteghem O, Allegra F et al. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. Br Med J 2003;326:13671372.
  • 6
    Lubach D, Bensmann A, Bornemann U. Steroid induced dermal atrophy. Investigations on discontinuous application. Dermatologica 1989;179:6772.
  • 7
    Kang S, Lucky AW, Pariser D, Lawrence I, Hanifin JM for the Tacrolimus Ointment Study Group. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 2001;44(Suppl.):S58S64.
  • 8
    Reitamo S, Wollenberg A, Schoepf E, Perrot JL, Marks R, Ruzicka T et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. Arch Dermatol 2000;136:9991006.
  • 9
    Hanifin JM, Paller AS, Eichenfield L, Clark RA, Korman N, Weinstein G et al. Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis. J Am Acad Dermatol 2005;53:S186S194.
  • 10
    Remitz A, Harper J, Rustin M, Goldschmidt WFM, Palatsi R, Van Der Valk PGM et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. Acta Derm Venereol 2007;87:5461.
  • 11
    Rubins A, Gutmane R, Valdmane N, Stevenson P, Foster C, Undre N. Pharmacokinetics of 0.1% tacrolimus ointment after first and repeated application to adults with moderate to severe atopic dermatitis. J Invest Dermatol 2005;125:6871.
  • 12
    Harper J, Smith C, Rubins A, Green A, Jackson K, Zigure S et al. A multicenter study of the pharmacokinetics of tacrolimus ointment after first and repeated application to children with atopic dermatitis. J Invest Dermatol 2005;124:695699.
  • 13
    Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980;92(Suppl.):4447.
  • 14
    Rajka G, Langeland T. Grading of severity of atopic dermatitis. Acta Derm Venereol 1989;144(Suppl.):1314.
  • 15
    Eichenfield LF, Lucky AW, Boguniewicz M, Langley RGB, Cherill R, Marshall K et al. Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol 2002;46:495504.
  • 16
    Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Exp Dermatol 2001;10:1118.
  • 17
    Finlay AK, Khan GK. Dermatology life quality index (DLQI). A simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210216.
  • 18
    Meurer M, Folster-Hoelst R, Wozel G, Weidinger G, Jünger M, Bräutigam M. Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study. Dermatology 2002;205:271277.
  • 19
    Reitamo S, Harper J, Bos JD, Cambazard F, Bruijnzeel-Koomen C, Valk P et al. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. Br J Dermatol 2004;150:554562.
  • 20
    Fleischer AB, Ling M, Eichenfeld L, Satoi Y, Jaracz E, Rico MJ et al. Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections. J Am Acad Dermatol 2002;47:562570.
  • 21
    Bonifazi E, Garofalo L, Pisani V, Meneghini CL Role of some infectious agents in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1985;114:98100.
  • 22
    David TJ, Longson M Herpes simplex infections in atopic eczema. Arch Dis Child 1985;60:166167.